Publikationer

Sortér efter: Dato | Forfatter | Titel

Heinz, J. L., Swagemakers, S. M. A., von Hofsten, J., Helleberg, M., Thomsen, M. M., De Keukeleere, K., de Boer, J. H., Ilginis, T., Verjans, G. M. G. M., van Hagen, P. M., van der Spek, P. J. & Mogensen, T. H. (2023). Whole exome sequencing of patients with varicella-zoster virus and herpes simplex virus induced acute retinal necrosis reveals rare disease-associated genetic variants. Frontiers in Molecular Neuroscience, 16, Artikel 1253040. https://doi.org/10.3389/fnmol.2023.1253040
Stærke, N. B., Weinreich, U. M., Jensen, T. T., Hilberg, O., Wejse, C. & Fløe, A. (2022). A cross-sectional study of risk factors for TB among socially marginalised people. International Journal of Tuberculosis and Lung Disease, 26(2), 166-168. https://doi.org/10.5588/ijtld.21.0626
Rosás-Umbert, M., Gunst, J. D., Pahus, M. H., Olesen, R., Schleimann, M., Denton, P. W., Ramos, V., Ward, A., Kinloch, N. N., Copertino, D. C., Escribà, T., Llano, A., Brumme, Z. L., Brad Jones, R., Mothe, B., Brander, C., Fox, J., Nussenzweig, M. C., Fidler, S. ... Søgaard, O. S. (2022). Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity. Nature Communications, 13, Artikel 6473. https://doi.org/10.1038/s41467-022-34171-2
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., O’Farrelly, C., Novelli, G., Rodríguez-Gallego, C., Haerynck, F., Prando, C., Pujol, A., Casanova, J. L. & COVID Human Genetic Effort (2022). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, 23(2), 159-164. https://doi.org/10.1038/s41590-021-01030-z
Rasmussen, T. A., Ahuja, S. K., Kuwanda, L., Vjecha, M. J., Hudson, F., Lal, L., Rhodes, A., Chang, J., Palmer, S., Auberson-Munderi, P., Mugerwa, H., Wood, R., Badal-Faesen, S., Pillay, S., Mngqibisa, R., LaRosa, A., Hildago, J., Petoumenos, K., Chiu, C. ... Wright, E. J. (2022). Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75(10), 1781-1791. https://doi.org/10.1093/cid/ciac249
Chupp, G., Spichler-Moffarah, A., Søgaard, O. S., Esserman, D., Dziura, J., Danzig, L., Chaurasia, R., Patra, K. P., Salovey, A., Nunez, A., May, J., Astorino, L., Patel, A., Halene, S., Wang, J., Hui, P., Patel, P., Lu, J., Li, F. ... Vinetz, J. M. (2022). A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste. medRxiv. https://doi.org/10.1101/2022.01.28.22270035